{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:11:33Z","timestamp":1790745093919,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T00:00:00Z","timestamp":1132617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00259-005-1921-x","type":"journal-article","created":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T15:39:43Z","timestamp":1132587583000},"page":"248-253","source":"Crossref","is-referenced-by-count":79,"title":["Comparative value of brain perfusion SPECT and [123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Haruo","family":"Hanyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishiro","family":"Chikamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,22]]},"reference":[{"key":"1921_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19\u201328","journal-title":"Lancet Neurol"},{"key":"1921_CR2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113\u201324","journal-title":"Neurology"},{"key":"1921_CR3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","volume":"47","author":"RL Albin","year":"1996","unstructured":"Albin RL, Minoshima S, D\u2019Amato CJ, Frey KA, Kuhl DA, Sima AAF. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996;47:462\u20136","journal-title":"Neurology"},{"key":"1921_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.51.1.125","volume":"51","author":"K Ishii","year":"1998","unstructured":"Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer\u2019s disease. Neurology 1998;51:125\u201330","journal-title":"Neurology"},{"key":"1921_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7342","volume":"162","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000;162:247\u201356","journal-title":"Exp Neurol"},{"key":"1921_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S, Foster NL, Sima AAF, Frey KA, Albin RL, Kuhl DE. Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358\u201365","journal-title":"Ann Neurol"},{"key":"1921_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.53.2.413","volume":"53","author":"K Ishii","year":"1999","unstructured":"Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53:413\u20136","journal-title":"Neurology"},{"key":"1921_CR8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","volume":"56","author":"K Lobotesis","year":"2001","unstructured":"Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643\u20139","journal-title":"Neurology"},{"key":"1921_CR9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00259-002-0919-x","volume":"29","author":"J Pasquier","year":"2002","unstructured":"Pasquier J, Michel B, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL. Value of 99mTc-ECD SPET for diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 2002;29:1342\u20138","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1921_CR10","first-page":"320","volume":"24","author":"E Donnemiller","year":"1997","unstructured":"Donnemiller E, Heilmann J, Wenning G, Berger W, Decristoforo C, Moncayo R, et al. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-\u03b2-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 1997;24:320\u20135","journal-title":"Eur J Nucl Med"},{"key":"1921_CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-002-0778-5","volume":"29","author":"SJ Colloby","year":"2002","unstructured":"Colloby SJ, Fenwick JD, Williams D, Paling SM, Lobotesis K, Ballard C, et al. A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer\u2019s disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002;29:615\u201322","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1921_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000085070","volume":"20","author":"S Shimizu","year":"2005","unstructured":"Shimizu S, Hanyu H, Kanetaka H, Iwamoto T, Koizumi K, Abe K. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using brain SPECT. Dement Geriatr Cogn Disord 2005;20:25\u201330","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1921_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. 123I-metaiodobenzyl guanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1999;67:189\u201394","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1921_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"J Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang E-H, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000;27:566\u201373","journal-title":"Eur J Nucl Med"},{"key":"1921_CR15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 1999;53:1020\u20135","journal-title":"Neurology"},{"key":"1921_CR16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","volume":"18","author":"F Courbon","year":"2003","unstructured":"Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc J-L, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease. Mov Disord 2003;18:890\u20137","journal-title":"Mov Disord"},{"key":"1921_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","volume":"71","author":"M Yoshita","year":"2001","unstructured":"Yoshita M, Taki J, Yamada M. A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2001;71:583\u20138","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1921_CR18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","volume":"70","author":"H Watanabe","year":"2001","unstructured":"Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, et al. Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2001;70:781\u20133","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1921_CR19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2169\/internalmedicine.42.686","volume":"42","author":"T Oide","year":"2003","unstructured":"Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer\u2019s disease and dementia with Lewy bodies. Intern Med 2003;42:686\u201390","journal-title":"Intern Med"},{"key":"1921_CR20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 1984;34:939\u201344","journal-title":"Neurology"},{"key":"1921_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","volume":"13","author":"KK Solanski","year":"1992","unstructured":"Solanski KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513\u201321","journal-title":"Nucl Med Commun"},{"key":"1921_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189\u201398","journal-title":"J Psychiatr Res"},{"key":"1921_CR23","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238\u201348","journal-title":"J Nucl Med"},{"key":"1921_CR24","volume-title":"Co-planar stereotactic atlas of the human brain","author":"J Talairach","year":"1998","unstructured":"Talairach J, Tournoux P. Co-planar stereotactic atlas of the human brain. New York: Thieme; 1998"},{"key":"1921_CR25","first-page":"1528","volume":"35","author":"S Minoshima","year":"1994","unstructured":"Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528\u201337","journal-title":"J Nucl Med"},{"key":"1921_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02988523","volume":"17","author":"S Mizumura","year":"2003","unstructured":"Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, et al. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 2003;17:289\u201395","journal-title":"Ann Nucl Med"},{"key":"1921_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02988527","volume":"17","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Momose M, Kanaya S, Kondo C, Kusakabe K, Mitsuhashi N. Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems. Ann Nucl Med 2003;17:309\u201313","journal-title":"Ann Nucl Med"},{"key":"1921_CR28","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.51.6.1760","volume":"51","author":"C Ballard","year":"1998","unstructured":"Ballard C, Shaw F, McKeith I, Kenny RA. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 1998;51:1760\u20132","journal-title":"Neurology"},{"key":"1921_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1995.tb05836.x","volume":"91","author":"A Algotsson","year":"1995","unstructured":"Algotsson A, Viitanen M, Winblad B, Solders G. Autonomic dysfunction in Alzheimer\u2019s disease. Acta Neurol Scand 1995;91:14\u20138","journal-title":"Acta Neurol Scand"},{"key":"1921_CR30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ageing\/23.5.400","volume":"23","author":"S-J Wang","year":"1994","unstructured":"Wang S-J, Liao K-K, Fuh J-L, Lin K-N, Wu Z-A, Liu C-Y, et al. Cardiovascular autonomic functions in Alzheimer\u2019s disease. Age Ageing 1994;23:400\u20134","journal-title":"Age Ageing"},{"key":"1921_CR31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0197-4580(01)00210-X","volume":"22","author":"T Szili-Torok","year":"2001","unstructured":"Szili-Torok T, Kalman J, Paprika D, Dibo G, Rozsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer\u2019s and Parkinson\u2019s disease. Neurobiol Aging 2001;22:435\u20138","journal-title":"Neurobiol Aging"},{"key":"1921_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00686763","volume":"6","author":"T Ishii","year":"1966","unstructured":"Ishii T. Distribution of Alzheimer\u2019s neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol 1966;6:181\u20137","journal-title":"Acta Neuropathol"},{"key":"1921_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1212\/WNL.35.1.123","volume":"35","author":"T McDuff","year":"1985","unstructured":"McDuff T, Sumi SM. Subcortical degeneration in Alzheimer\u2019s disease. Neurology 1985;35:123\u20136","journal-title":"Neurology"},{"key":"1921_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(81)90269-5","volume":"ii","author":"CM Yates","year":"1981","unstructured":"Yates CM, Ritchie IM, Simpson J. Noradrenalin in Alzheimer-type dementia and Down\u2019s syndrome. Lancet 1981;ii:39\u201340","journal-title":"Lancet"},{"key":"1921_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2005;76:249\u201351","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1921_CR36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","volume":"18","author":"J Taki","year":"2004","unstructured":"Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453\u201361","journal-title":"Ann Nucl Med"},{"key":"1921_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/089198870201500405","volume":"15","author":"S Minoshima","year":"2002","unstructured":"Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. J Geriatr Psychiatry Neurol 2002;15:200\u20139","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1921_CR38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.51.2.357","volume":"51","author":"M Hashimoto","year":"1998","unstructured":"Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies. A volumetric MRI study. Neurology 1998;51:357\u201362","journal-title":"Neurology"},{"key":"1921_CR39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.54.6.1304","volume":"54","author":"R Barber","year":"2000","unstructured":"Barber R, Ballard C, McKeith IG, Gholkar A, O\u2019Brien JT. MRI volumetric study of dementia with Lewy bodies. A comparison with AD and vascular dementia. Neurology 2000;54:1304\u20139","journal-title":"Neurology"},{"key":"1921_CR40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1006\/nimg.2002.1197","volume":"17","author":"EJ Burton","year":"2002","unstructured":"Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 2002;17:618\u201330","journal-title":"Neuroimage"},{"key":"1921_CR41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2005.01.088","volume":"380","author":"H Hanyu","year":"2005","unstructured":"Hanyu H, Shimizu S, Tanaka Y, Kanetaka H, Iwamoto T, Abe K. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer\u2019s disease. Neurosci Lett 2005;380:166\u20139","journal-title":"Neurosci Lett"},{"key":"1921_CR42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Waker","year":"2002","unstructured":"Waker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134\u201340","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1921_CR43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","volume":"61","author":"JT O\u2019Brien","year":"2004","unstructured":"O\u2019Brien JT, Colloby S, Fenwick J, Williams D, Firbank M, Burn D, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004;61:919\u201325","journal-title":"Arch Neurol"},{"key":"1921_CR44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuroimage.2004.06.045","volume":"23","author":"SJ Colloby","year":"2004","unstructured":"Colloby SJ, O\u2019Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, et al. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer\u2019s disease and Parkinson\u2019s disease. Neuroimage 2004;23:956\u201366","journal-title":"Neuroimage"},{"key":"1921_CR45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practical parameter: diagnosis of dementia (an evidence-based review), report of the quality standards subcommittee of the American Academy of neurology. Neurology 2001;56:1143\u201353","journal-title":"Neurology"},{"key":"1921_CR46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","volume":"54","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Ballard CG, Perry RH, Ince PG, O\u2019Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050\u20138","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-005-1921-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1921-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:58:52Z","timestamp":1558713532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-005-1921-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,22]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1007\/s00259-005-1921-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,22]]}}}